Fasting glucose normalization, improved insulin sensitivity, and better lipid profiles were observed across dose groups, with particular significance at 4mg and above
SCFAs, particularly butyrate, have been shown to inhibit NF-B activation by preventing the phosphorylation and degradation of inhibitor proteins (IBs), thereby mitigating inflammatory responses and promoting gut homeostasis (Yao et al., 2024
After the muscle biopsy the following baseline assessments were performed: upper and lower (stronger non-biopsied leg) extremity strength testing by dynamometry and the 6-min walk test, RAND SF-36 questionnaire, and Stanford exercise behavior scale
That isnt a fringe forum
They will also explain the procedure, the benefits, and any potential risks or side effects